Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AGfiledCriticalSchering AG
Publication of ES247743A1publicationCriticalpatent/ES247743A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Procedure for obtaining Rºntgen contrast media characterized by being composed of combinations (industrial products) of the general formula ** (See formula) ** wherein X represents hydrogen or iodine, R1 and/or R2 hydrogen or an alkyl group and hydrogen B, the acyl radical of a lower aliphatic carboxylic acid or the group (see formula), and by its salts with physiologically tolerable inorganic and/or organic bases. (Machine-translation by Google Translate, not legally binding)
ES0247743A1958-03-071959-03-06Procedure for the obtaining of rºntgen contrast media (Machine-translation by Google Translate, not legally binding)
ExpiredES247743A1
(en)
Procedure for the obtaining of new arilalkilcarboxylic acids, its basic esters, acid salts and quaternary salts (Machine-translation by Google Translate, not legally binding)
Procedure for the obtaining of alpha acid, beta-bis- (aminofenil) -propionicos yodados in the nucleus used in the rºntgen contrast media (Machine-translation by Google Translate, not legally binding)